• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.

作者信息

Song Won Kyung, Koh Hyoung Jun, Kwon Oh Woong, Byeon Suk Ho, Lee Sung Chul

机构信息

Department of Ophthalmology, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Acta Ophthalmol. 2009 Feb;87(1):100-1. doi: 10.1111/j.1600-0420.2007.01136.x.

DOI:10.1111/j.1600-0420.2007.01136.x
PMID:19178391
Abstract
摘要

相似文献

1
Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发的脉络膜新生血管
Acta Ophthalmol. 2009 Feb;87(1):100-1. doi: 10.1111/j.1600-0420.2007.01136.x.
2
Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).脉络膜骨瘤相关脉络膜新生血管对玻璃体内注射贝伐单抗（阿瓦斯汀）的显著反应。
Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1731-3. doi: 10.1007/s00417-007-0636-z. Epub 2007 Jul 25.
3
Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发脉络膜新生血管膜
Eur J Ophthalmol. 2008 May-Jun;18(3):466-8. doi: 10.1177/112067210801800327.
4
Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.眼内注射贝伐单抗治疗与骨瘤相关的脉络膜视网膜下液。
Retina. 2010 Jun;30(6):945-51. doi: 10.1097/IAE.0b013e3181c720ca.
5
Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.抗血管内皮生长因子疗法治疗脉络膜骨瘤相关脉络膜新生血管的疗效
Retina. 2014 Sep;34(9):1750-6. doi: 10.1097/IAE.0000000000000187.
6
Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.玻璃体内注射贝伐单抗治疗病理性近视性脉络膜新生血管
Retina. 2006 Nov-Dec;26(9):1093-4. doi: 10.1097/01.iae.0000254896.78766.74.
7
Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.玻璃体内注射贝伐单抗治疗视乳头周围典型性视网膜下新生血管形成
Acta Ophthalmol Scand. 2007 May;85(3):340-1. doi: 10.1111/j.1600-0420.2006.00832.x.
8
Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.玻璃体腔注射贝伐单抗治疗病理性近视性脉络膜新生血管
Retina. 2006 Oct;26(8):960-3. doi: 10.1097/01.iae.0000240121.28034.c3.
9
Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.玻璃体内注射贝伐单抗治疗血管样条纹继发的脉络膜新生血管。
Arch Ophthalmol. 2007 Oct;125(10):1422-3. doi: 10.1001/archopht.125.10.1422.
10
The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).玻璃体内注射贝伐单抗治疗脉络膜新生血管膜（CNVMs）。
Retina. 2008 Jun;28(6):910; author reply 910-1. doi: 10.1097/IAE.0b013e31816d81d0.

引用本文的文献

1
Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report.玻璃体内注射雷珠单抗与光动力疗法治疗脉络膜骨瘤继发脉络膜新生血管：7年随访病例报告
Int J Ophthalmol. 2021 Jun 18;14(6):940-944. doi: 10.18240/ijo.2021.06.22. eCollection 2021.
2
Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective.妊娠期玻璃体内抗血管内皮生长因子药物：当前观点。
Int Ophthalmol. 2021 Feb;41(2):743-751. doi: 10.1007/s10792-020-01610-2. Epub 2020 Oct 12.
3
Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization.
玻璃体腔内注射贝伐单抗治疗无脉络膜新生血管的脉络膜骨瘤
J Ophthalmic Vis Res. 2015 Oct-Dec;10(4):484-6. doi: 10.4103/2008-322X.176905.
4
Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.孕期玻璃体内注射抗血管内皮生长因子：病例系列及文献综述
J Ocul Pharmacol Ther. 2015 Dec;31(10):605-10. doi: 10.1089/jop.2015.0056. Epub 2015 Aug 24.
5
Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.玻璃体内注射贝伐单抗治疗脉络膜骨瘤相关脉络膜新生血管的长期疗效。
Clin Ophthalmol. 2015 Mar 3;9:429-37. doi: 10.2147/OPTH.S78817. eCollection 2015.
6
Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.玻璃体内注射阿柏西普对脉络膜骨瘤继发脉络膜新生血管进行挽救治疗，此类患者对玻璃体内注射贝伐单抗和雷珠单抗无反应。
Int Ophthalmol. 2015 Jun;35(3):441-4. doi: 10.1007/s10792-015-0059-5. Epub 2015 Mar 12.
7
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.玻璃体内注射抗血管内皮生长因子治疗脉络膜骨瘤所致脉络膜新生血管的作用
J Ophthalmol. 2014;2014:210458. doi: 10.1155/2014/210458. Epub 2014 Jul 23.
8
Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.一名儿童双侧脉络膜骨瘤伴脉络膜新生血管膜接受贝伐单抗治疗。
Middle East Afr J Ophthalmol. 2014 Jul-Sep;21(3):265-7. doi: 10.4103/0974-9233.134692.
9
Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.光动力疗法联合玻璃体内注射贝伐单抗治疗脉络膜骨瘤继发脉络膜新生血管患者
Korean J Ophthalmol. 2012 Dec;26(6):478-80. doi: 10.3341/kjo.2012.26.6.478. Epub 2012 Nov 12.
10
Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma.玻璃体内注射雷珠单抗治疗脉络膜骨瘤所致脉络膜新生血管的长期随访
Case Rep Ophthalmol. 2012 May;3(2):200-4. doi: 10.1159/000339624. Epub 2012 Jun 12.